Back to CITIGROUP INC CITIGROUP INC

ARTLARTL
2 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in ARTELO BIOSCIENCES INC

No. Citigroup exited its ARTL (Artelo Biosciences) position in Q2 2026. Its Q1 2026 13F listed 3,076 shares worth $23,316. Citigroup first reported ARTL in Q1 2026 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$23,316

Total Shares Change

-3,076

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$10.08
0
2026-Q1
New
3,076
-
$23,3160.0%$68.22
29

Other major holders of ARTL: JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used